The U.S. Food and Drug Administration (FDA) is experiencing abrupt and noticeable personnel changes as it continues to clash with the Health and Human Services (HHS), the department that oversees the agency and its operations.
As reported in POLITCO, the FDA on Monday went through three different top lawyer nominees after the agency’s top lawyer resigned prior to the inauguration of President-elect Joe Biden. Stacy Cline Amin stepped down as chief counsel, with the FDA announcing Mark Raza as the acting replacement for the position.
